WHO ICTRP trial
Study on treatment of traditional Chinese medicine of drug-induced liver injury…
ChiCTR2000032581 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000032581 |
|---|---|
| Public title | Study on treatment of traditional Chinese medicine of drug-induced liver injury: a randomized controlled trial. |
| Scientific title | Study on treatment of traditional Chinese medicine of anti-tuberculosis drug-induced liver injury |
| Primary sponsor | Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Drug-induced liver injury |
| Interventions | experimental group:Chinese medicine free decoction granules;control group:hepatoprotective Western Medicine |
| Registration date | May 3, 2020 |
| Target size | experimental group:60;control group:60 |
| Secondary IDs | ChiMCTR2000003269 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: